Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
PeptiDream Inc.
ISIN JP3836750004
|WKN A1W0KK
Market cap (in EUR)
1,241 m
Country
Japan
Sector
Healthcare
Dividend yield
0.00%
Overview
Description
PeptiDream, Inc. engages in the biopharmaceutical business that includes research and development of non-standard peptide therapeutics. It operates through Drug Discovery and Development Business segment. The Drug Discovery and Development Business segment provides macrocyclic peptides based on its proprietary Peptide Discovery Platform System (PDPS) and engages in collaborative drug discovery research and development, technology licensing of PDPS, and expansion of pipeline through strategic alliances. The company was founded by Kiichi Kubota and Hiroaki Suga on July 3, 2006 and is headquartered in Kawasaki, Japan.
Healthcare Healthcare Services Miscellaneous Healthcare Japan
Financials
Key metrics
| Market capitalisation, EUR | 1,241 m |
| EPS, EUR | -0.27 |
| P/B ratio | 4.3 |
| P/E ratio | 14.7 |
| Dividend yield | 0.00% |
Income statement (2024)
| Revenue, EUR | 285 m |
| Net income, EUR | 92 m |
| Profit margin | 32.17% |
What ETF is PeptiDream Inc. in?
There are 39 ETFs which contain PeptiDream Inc.. All of these ETFs are listed in the table below. The ETF with the largest weighting of PeptiDream Inc. is the L&G Healthcare Technology & Innovation UCITS ETF USD Acc.
Latest articles
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.